About

After more than 30 years of scientific research de Faire Medical AB was founded in 2021with a clear Vision uncovering the full potential of applying microbial solutions to a specific organic substrate, and a unique technology of targeting bacterial strains into functional dietary supplements

Our History

1970-1980
1970-1980

Early observations that farmed animals suffering from intestinal inflammations recovered from eating fermented rice bran.

1990
1990


In late 1990s, a pro-/prebiotic dietary supplement for human uses was developed and safety studies designed as open case studies were initiated. No side effects or adverse reactions were detected as a single treatment or concomitantly with other commonly used drugs, i.e. anti-inflammatory, heart medicines, antibiotics and more.

2000
2000


In the early 2000 catalytic targeting of consortium for preferential metabolic actions was developed.

2010-2020
2010-2020

First study on alcohol digestion was conducted.

2020
2020

In 2020 an additional study on alcohol digestion and a study on Type 2 diabetes were conducted with most positive outcomes.

2021
2021


In February 2021 de Faire Medical AB was incorporated

2022
2022

July 2022

Launch of Myrkl in the UK & Ireland